As the global economic crisis takes an increasingly steep toll on access to HIV/AIDS drugs in the developing world, the new head of UNAIDS, Michel Sidibe, floated an innovative solution—calling for Africa to develop its own generic manufacturing capacity for antiretroviral drugs.
Sidibe said such a move would increase access to ARVs, while also developing a profitable business for the continent.
“It’s important politically, it’s important economically, it’s important for the integration of Africa in the global market,” Sidibe told reporters during a trip to the Ethiopian capital Addis Ababa, according to this Reuters report.
Meanwhile, Pakistan faces the demise of one of its major HIV/AIDS treatment and prevention programs. This story in IRIN/PlusNews says funding for the program through USAID is about to run out, so the program will be halted.
Although one health official expressed hope that it could be restarted soon, it was far from clear where the money for that would come from. Click here to read more.